April 19, 2019
- Compounding Research
- National Academies of Science, Engineering, and Medicine (NASEM) Study on the Clinical Utility of Treating Patients with Compounded “Bioidentical” Hormone Therapy
- National Academies of Science, Engineering, and Medicine (NASEM) Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Products
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Trials Snapshots: MAYZENT
- FDA Drug Shortages
- Dextrose 5% Injection Bags (Updated - Currently in Shortage)
- Folic Acid Tablets, USP (New - Discontinuation)
- Fluorescein Strips (Updated - Currently in Shortage)
- Hydrocortisone Tablets, USP (New - Discontinuation)
- Isosorbide Mononitrate Extended-Release Tablets, USP (New - Discontinuation)
- Modafinil Tablets (New - Discontinuation)
- Morphine Sulfate Extended-Release Tablets (New - Discontinuation)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage)
- Spironolactone Tablets, USP (New - Discontinuation)
- Sterile Water (Updated - Currently in Shortage)
- Testosterone Gel 1% (New - Discontinuation)
- FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan(updated)
- First Generic Drug Approvals (updated)
- Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting Meeting Information (updated)
- Annual CDER Reports to Congress
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario